Suppr超能文献

Interleukin-6 receptor antagonist therapy to treat SARS-CoV-2 driven inflammatory syndrome in a kidney transplant recipient.

作者信息

Allam Sridhar R, Dao Ann, Madhrira Machaiah M, Antiporta Philip B, Nair Ranjit R, Guiteau Jacfranz J, Reyad Ashraf I

机构信息

Tarrant Nephrology Associates/Premier Physicians Group Health, Fort Worth, Texas, USA.

Medical City Fort Worth Transplant Institute, Fort Worth, Texas, USA.

出版信息

Transpl Infect Dis. 2020 Aug;22(4):e13326. doi: 10.1111/tid.13326. Epub 2020 Jun 5.

Abstract
摘要

相似文献

1
Interleukin-6 receptor antagonist therapy to treat SARS-CoV-2 driven inflammatory syndrome in a kidney transplant recipient.
Transpl Infect Dis. 2020 Aug;22(4):e13326. doi: 10.1111/tid.13326. Epub 2020 Jun 5.
2
Tocilizumab, an anti-IL-6 receptor antibody, to treat COVID-19-related respiratory failure: a case report.
Ann Oncol. 2020 Jul;31(7):961-964. doi: 10.1016/j.annonc.2020.03.300. Epub 2020 Apr 2.
3
Cytokine Storm Drugs Move from CAR T to COVID-19.
Cancer Discov. 2020 Jul;10(7):OF8. doi: 10.1158/2159-8290.CD-ND2020-008. Epub 2020 May 5.
4
Kidney Transplantation and COVID-19.
R I Med J (2013). 2020 Sep 4;103(8):34-37.
5
Interleukin 6 levels after tocilizumab administration in transplant recipients with COVID-19.
Kidney Int. 2020 Oct;98(4):1054. doi: 10.1016/j.kint.2020.06.025. Epub 2020 Jul 8.
6
Tocilizumab for Hemophagocytic Syndrome in a Kidney Transplant Recipient With COVID-19.
Ann Intern Med. 2020 Sep 15;173(6):501-503. doi: 10.7326/L20-0419. Epub 2020 May 18.
7
Early tocilizumab treatment could improve survival among COVID-19 patients.
Clin Exp Rheumatol. 2020 May-Jun;38(3):578. Epub 2020 May 27.
8
Treat 2019 novel coronavirus (COVID-19) with IL-6 inhibitor: Are we already that far?
Drug Discov Ther. 2020;14(2):100-102. doi: 10.5582/ddt.2020.03006.
9
Lack of tocilizumab effect on mortality in COVID19 patients.
Sci Rep. 2020 Oct 13;10(1):17100. doi: 10.1038/s41598-020-74328-x.
10
Tocilizumab in the treatment of a critical COVID-19 patient: a case report.
Eur Rev Med Pharmacol Sci. 2020 May;24(10):5783-5787. doi: 10.26355/eurrev_202005_21372.

引用本文的文献

1
Recent advances in passive immunotherapies for COVID-19: The Evidence-Based approaches and clinical trials.
Int Immunopharmacol. 2022 Aug;109:108786. doi: 10.1016/j.intimp.2022.108786. Epub 2022 Apr 21.
2
Coronavirus-19 infection in kidney transplant recipients: A comprehensive review.
Indian J Urol. 2022 Apr-Jun;38(2):110-114. doi: 10.4103/iju.iju_430_21. Epub 2022 Apr 1.
4
SARS-CoV-2 in Solid Organ Transplant Recipients: A Structured Review of 2020.
Transplant Proc. 2021 Oct;53(8):2421-2434. doi: 10.1016/j.transproceed.2021.08.019. Epub 2021 Aug 16.
7
COVID-19 in SOT versus non-SOT.
Am J Transplant. 2021 Jun;21(6):2304-2305. doi: 10.1111/ajt.16481. Epub 2021 Feb 8.
8
COVID-19 in solid organ transplant recipients: A systematic review and meta-analysis of current literature.
Transplant Rev (Orlando). 2021 Jan;35(1):100588. doi: 10.1016/j.trre.2020.100588. Epub 2020 Nov 14.
10
Management of Pediatric Kidney Transplant Patients During the COVID-19 Pandemic: Guidance From the Canadian Society of Transplantation Pediatric Group.
Can J Kidney Health Dis. 2020 Nov 13;7:2054358120967845. doi: 10.1177/2054358120967845. eCollection 2020.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验